Quantcast

Industry news that matters to you.  Learn more

Thermo Fisher Scientific Signs Agreement to Make its Biomarker Assays Available on Alere Triage Systems

Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a long-term license agreement with Alere Inc. to integrate its novel Thermo Scientific B.R.A.H.M.S. biomarker assays on Alere’s leading point-of-care Triage platform. Alere, formerly Inverness Medical Innovations, is a global leader in rapid point-of-care diagnostics. Increased availability of biomarker-based testing on the Triage platform will lead to improved patient care in hospitals and primary care facilities.